Information  X 
Enter a valid email address

Fevertree Drinks PLC (FEVR)

  Print      Mail a friend

Monday 18 November, 2019

Fevertree Drinks PLC

Director/PDMR Shareholding

RNS Number : 6602T
Fevertree Drinks PLC
18 November 2019

18 November 2019

Fevertree Drinks plc

Grant of Options

Fevertree Drinks plc (the "Company") announces the grant of options over a total of 64,466 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company with an exercise price of 0.25 pence.

On 8th May 2019, the following options were issued to the Company's Executive Directors, pursuant to the Company's Long Term Incentive Plan ("LTIP"):



Number of share options granted

Performance period

Vesting period

Exercise price

Tim Warrillow

Chief Executive Officer


1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share

Andy Branchflower

Finance Director


1 January 2019 to 31 December 2021

3 years commencing on 8 May 2019

0.25p per share


The number of Ordinary Shares stated is the maximum number that could be issued to each Executive Director upon full satisfaction of the performance conditions attached to the 2019 awards.


The performance conditions are based on the achievement of targets linked to the Company's FY2021 turnover (as regards 75% of each award) and FY2021 adjusted EBITDA (as regards 25% of each award)


Taking account of previous grants, the total number of unvested options held by the Executive Directors detailed in this announcement, pursuant to the Company's LTIP, is as follows:


Tim Warrillow - 135,123 share options

Andy Branchflower - 75,395 share options


This includes the awards granted in 2017 and 2018, further details of which have been disclosed in the relevant Directors Remuneration Report.


For further information:


Fevertree Drinks plc

 +44 (0)20 7349 4922

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director

Numis Securities - Nominated Adviser and Broker

+44 (0)20 7260 1000

Garry Levin

Matt Lewis

Hugo Rubinstein


Investec Bank plc - Joint Broker

+44 (0)20 7597 5970

David Flin

Alex Wright

David Anderson




Brunswick Group

+44 (0)20 7404 5959

Jonathan Glass

Fiona Micallef-Eynaud



Notes to Editors:


Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations


Details of the persons discharging managerial responsibilities / person closely associated



1. Tim Warrillow

2. Andy Branchflower


Reason for the notification



1.   Chief Executive Officer

2.   Finance Director


Initial notification /Amendment

Initial notification


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



Fevertree Drinks plc





Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Description of the financial instrument, type of instrument

Ordinary shares of 0.25 pence each


Identification code



Nature of the transaction

Grant of options


Price(s) and volume(s)

Exercise Prices per share


1. 0.25p

2. 0.25p

1. 39,240

2. 25,226



Aggregated information

- Aggregated volume

- Price



Date of the transaction

8th May 2019


Place of the transaction

Outside a trading venue


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t